Skip to content
Riskpilot
← Back to search
Sign in
Get full access
HB MEDICAL SCANDINAVIA A/S
A/S
Dissolved
CVR 37638862
Johann Gutenbergs Vej 5, 8200
Aarhus N
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2016
— employees
Watchlist
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
HB MEDICAL SCANDINAVIA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (2)
HF
Hans Flemming Haagen Jensen
Chief Executive Officer
Chief Executive Officer
2016 – 2019
JS
Jens-Nikolaj Schøier
Management
Management
2019 – 2019
Board of directors
Non-executive oversight
Name
Role
Member since
Former (8)
HB
Helle Bøwadt
Deputy Chairman
2016 – 2019
SJ
Søren Johannes Kjær Henningsen
Deputy Chairman
2016 – 2016
HG
Henrik Grundtvig
Chairman
2019 – 2022
MG
Michael Grundtvig
Board of Directors
2019 – 2022
LK
Lars Karlsmose
Chairman
2018 – 2019
PL
Per Ludvigsen
Chairman
2019 – 2019
MS
Mohammad Sohail Asghar
Board of Directors
2019 – 2019
LG
Lars Grundtvig
Chairman
2016 – 2018
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
HB-MEDICAL HOLDING ApS
Company
25–33.32%
25–33.32%
2016
LYMED Holding ApS
Company
100%
100%
2019
JCNS Holding ApS
Company
100%
100%
2019
XGX Pharma ApS
Company
100%
100%
2019
LYKKENSDAL HOLDING ApS
Company
66.67–89.99%
66.67–89.99%
2016
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on HB MEDICAL SCANDINAVIA A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network